Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling
Abstract Sodium-dependent glucose co-transporter 1 (SGLT1) is a solute carrier responsible for active glucose absorption. SGLT1 is present in both the renal tubules and small intestine. In contrast, the closely related sodium-dependent glucose co-transporter 2 (SGLT2), a protein that is targeted in...
Main Authors: | Lindsey Burggraaff, Paul Oranje, Robin Gouka, Pieter van der Pijl, Marian Geldof, Herman W. T. van Vlijmen, Adriaan P. IJzerman, Gerard J. P. van Westen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Journal of Cheminformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13321-019-0337-8 |
Similar Items
-
Safe and pragmatic use of sodium-glucose co-transporter 2 (SGLT 2) inhibitors: medication counseling
by: S. Kalra, et al.
Published: (2016-08-01) -
SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
by: Swetha R. Kanduri, et al.
Published: (2020-08-01) -
A Computational Model of Kidney Function in a Patient with Diabetes
by: Rui Hu, et al.
Published: (2021-05-01) -
SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate
by: Michael S. Balzer, et al.
Published: (2020-11-01) -
Structure/Function Studies of the High Affinity Na+/Glucose Cotransporter (SGLT1)
by: Liu, Tiemin
Published: (2006)